|
The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- Cap-XX Ltd - Sydney, Australia-based designer and manufacturer of supercapacitors and energy management systems - Reports a narrowed loss before tax of A$1.5 million, about $1.1 million, for the six months that ended December 31, from A$1.7 million a year earlier. Revenue rises 9.0% to A$2.6 million from A$2.4 million, and Cap-XX reports a 43% decline in process and engineering expenses to A$648,958. Finance costs are also lower, down 26% at A$104,552. ‘The group enters the second half of FY26 with a further strengthened operational foundation, underpinned by improved systems, enhanced production visibility, and more robust financial controls. The board remains focused on leveraging this platform to drive further efficiency gains, improve margins, and convert the growing commercial pipeline into sustainable revenue growth,’ says the company. ---------- PACSCo Ltd - investment and sustainable development in Southern Africa - Reports a pretax loss of $1.6 million for the financial year that ended March 31, widened from $1.4 million a year earlier. Operating expenses fall 6.3% to $385,000 from $411,00, but finance costs rise 38% to $1.4 million from $1.0 million. Notes shareholders approved the disposal of its Mozambique operations to Chepstow Investments Ltd at a general meeting on March 31 last year. ‘With the transfer of control of operations of the Mozambique Agriculture Businesses to Chepstow, following shareholder approval of the disposal, the Mozambique businesses were deconsolidated at 31 March 2025. As at the date of this report, final completion of the disposal is still pending Bank of Mozambique (the Mozambique central bank) approval,’ says PACSCo. Notes that the long stop date for completion of the disposal was extended through agreement with Chepstow to March 31 this year. ---------- BSF Enterprise PLC - London-based biotech company is the owner of companies including 3D Bio-Tissues, a pioneer of lab-grown tissues, as well as the corneal replacement company Kerato - Reports a pretax loss of £1.2 million for the financial year ended September 30, narrowed from £1.8 million a year prior. Revenue falls 8.6% to £52,840 from £57,821, but the company reports a 16% decline in cost of sales to £70,999. Admin expenses fall 16% to £1.6 million from £1.9 million, while other income more than doubles to £424,420 from £158,688. ‘This year has been one of transformation and momentum. With a clear strategy, we are well-positioned to execute our goals in 2026. We do not anticipate the need to raise additional funds during the year and our renewed focus on commercialisation, partnerships, and sustainability will continue to drive our long-term value creation strategy,’ says Chair Geoff Baker. ---------- Various Eateries PLC - London-based operator of restaurant, clubhouse and hotel sites under the Coppa Club and Noci brands - Pretax loss narrows to £2.7 million for the financial year ended September 28, from £3.4 million a year prior. Revenue rises 5.8% to £52.4 million from £49.5 million, with like-for-like growth up 2% on-year. Notes that Coppa Club led group like-for-like growth, up 3%, and with particularly strong momentum in breakfast, up 10% on a lfl basis. Adds lunch also performed well as it improved 5% on a lfl basis. ‘In the current environment, we see the clearest near-term growth opportunity in further expanding Coppa Club, underpinned by the strength and versatility of its all-day proposition. Noci remains a newer, smaller part of the Group and continues to make steady progress, with further development of the offer planned in FY26,’ the company says. Discussing financial 2026 trading, the company says it entered the year in a ‘strong position’, with trading to-date ‘encouraging’. ---------- XP Factory PLC - London-based leisure and entertainment company - Reports record quarterly sales with UK Owned and Operated revenue growth of 4.2% in the 13 weeks to December 28. Also notes year-to-date unaudited pre-IFRS 16 adjusted earnings before interest, tax, depreciation and amortisation of £4.8 million for the 39 weeks to December 28, up by £100,000 on-year. Reports ‘exceptional trading’ at Escape Hunt O&O, with 10% UK O&O sales growth in the 13 weeks to December 28. Adds it has seen positive overall growth within Boom O&O, but with a continuing lfl sales decline with ongoing sector softness. Says that given the slower than expected Boom B2C performance over the festive period, which has persisted into January, it now expects full-year revenue and Ebitda to be below current market estimates. Says the board sees pre-IFRS16 adjusted Ebitda of between £5.0 million and £6.0 million for financial 2026. ‘Whilst the long-term growth opportunity remains highly attractive, due to challenging market conditions impacting LFL growth and cost inflation, the board has taken the prudent view to moderate the pace of new site openings in the near term. FY27 is also therefore expected to be a year of consolidation, with remaining uncertainty driven by market conditions,’ says XP Factory. Also on Monday, the company appoints James van den Bergh as independent non-executive chair, effective immediately. Notes he is currently chief executive at TruFin PLC. Says van den Bergh succeeds Richard Rose following the announcement in September of his intention to step down. ---------- Copyright 2026 Alliance News Ltd. All Rights Reserved.
|